Edition:
United States

Mauna Kea Technologies SAS (MKEA.PA)

MKEA.PA on Paris Stock Exchange

5.08EUR
6:59am EST
Change (% chg)

€0.58 (+12.89%)
Prev Close
€4.50
Open
€4.55
Day's High
€5.19
Day's Low
€4.55
Volume
1,240,122
Avg. Vol
694,806
52-wk High
€5.49
52-wk Low
€1.85

Latest Key Developments (Source: Significant Developments)

Mauna Kea Technologies says new Contact study analysis demonstrates Cellvizio’s ability to improve management of patients with pancreatic cysts
Monday, 30 Oct 2017 12:46pm EDT 

Oct 30 (Reuters) - MAUNA KEA TECHNOLOGIES SAS ::MAUNA KEA TECHNOLOGIES: NEW CONTACT STUDY ANALYSIS DEMONSTRATES CELLVIZIO’S ABILITY TO IMPROVE THE MANAGEMENT OF PATIENTS WITH PANCREATIC CYSTS.  Full Article

Mauna Kea Technologies Q3 sales down at 1.9‍​ million euros
Thursday, 19 Oct 2017 01:09pm EDT 

Oct 19 (Reuters) - MAUNA KEA TECHNOLOGIES SAS ::Q3 SALES EUR 1.9‍​ MILLION VERSUS EUR 2.1 MILLION YEAR AGO.  Full Article

Mauna Kea Technologies appoints Olivier Regnard as CFO
Tuesday, 17 Oct 2017 11:46am EDT 

Oct 17 (Reuters) - MAUNA KEA TECHNOLOGIES SAS ::MAUNA KEA TECHNOLOGIES APPOINTS OLIVIER REGNARD AS DEPUTY CEO AND CHIEF FINANCIAL OFFICER.  Full Article

Mauna Kea Technologies gets CE marking for the use of Cellvizio in robotized surgery‍​
Monday, 9 Oct 2017 11:42am EDT 

Oct 9 (Reuters) - MAUNA KEA TECHNOLOGIES SAS ::GETS CE MARKING FOR THE USE OF CELLVIZIO IN ROBOTIZED SURGERY‍​.  Full Article

Mauna Kea Technologies H1 net loss widens to ‍​5.8 million euros
Wednesday, 20 Sep 2017 11:46am EDT 

Sept 20 (Reuters) - MAUNA KEA TECHNOLOGIES SAS ::H1 NET LOSS EUR ‍​5.8 MILLION VERSUS LOSS OF EUR 4.9 MILLION YEAR AGO.H1 OPERATING LOSS EUR ‍​ 5.5 MILLION VERSUS EUR LOSS OF EUR 5.0 MILLION YEAR AGO.H1 REVENUE OF EUR 3.3 MILLION VERSUS EUR 4.5 MILLION YEAR AGO.  Full Article

Mauna Kea Technologies obtains FDA registration
Monday, 7 Aug 2017 12:34pm EDT 

Aug 7 (Reuters) - MAUNA KEA TECHNOLOGIES SAS ::OBTAINS FDA REGISTRATION FOR USE OF CELLVIZIO DURING SURGERIES.  Full Article

Mauna Kea Technologies: multicenter randomized controlled trial shows improved early stomach cancer detection with Cellvizio
Wednesday, 2 Aug 2017 11:46am EDT 

Aug 2 (Reuters) - MAUNA KEA TECHNOLOGIES SAS ::SAYS MULTICENTER RANDOMIZED CONTROLLED TRIAL SHOWS IMPROVED EARLY STOMACH CANCER DETECTION WITH CELLVIZIO.  Full Article

Mauna Kea Technologies H1 total revenue down at ‍​3.3 million euros
Tuesday, 25 Jul 2017 11:46am EDT 

July 25 (Reuters) - MAUNA KEA TECHNOLOGIES SAS ::H1 TOTAL REVENUE EUR ‍​3.3 MILLION VERSUS EUR 4.5 MILLION YEAR AGO.  Full Article

Mauna Kea Technologies announces benefits of using Cellvizio for characterizing upper urinary tract cancer
Monday, 19 Jun 2017 11:45am EDT 

June 19 (Reuters) - MAUNA KEA TECHNOLOGIES SAS : :MAUNA KEA TECHNOLOGIES: NEW PUBLICATION CONFIRMS BENEFITS OF USING CELLVIZIO FOR CHARACTERIZING UPPER URINARY TRACT CANCER.  Full Article

Mauna Kea Technologies FY total sales drops to 1.6 million euros
Wednesday, 19 Apr 2017 11:47am EDT 

April 19 (Reuters) - Mauna Kea Technologies SAS ::FY total sales EUR 1.6 million ($1.71 million) versus EUR 2.0 million year ago.  Full Article

BRIEF-Mauna Kea Technologies appoints Olivier Regnard as CFO

* MAUNA KEA TECHNOLOGIES APPOINTS OLIVIER REGNARD AS DEPUTY CEO AND CHIEF FINANCIAL OFFICER Source text for Eikon: Further company coverage: (Gdynia Newsroom)